​News Release

​National Heart Centre Singapore and Mayo Clinic to Advance Cardiovascular Care and Research

1. Cardio-oncology: An emerging field that focuses on protecting the heart health of cancer patients which is increasingly important in Asia given the growing burden of both heart and cancer conditions. As cancer therapies may affect cardiovascular function, the seamless integration of cardiology and oncology expertise ensures optimal patient care. Mayo Clinic has established specialised cardio-oncology clinics across various campuses to provide comprehensive cardiovascular care for cancer patients. Similarly, NHCS recognises the significance of this field and integrated care strategies to enhance treatment outcomes and quality of life in cancer patients. This alignment in clinical priorities presents valuable opportunities for both institutions to explore knowledge exchange, and potential collaborations in cardio-oncology education, research and clinical care.

2. Innovative Healthcare Solutions to Transform Cardiovascular Care: This collaboration also brings together complementary strengths in healthcare innovation, particularly in novel biomarkers and digital imaging technologies to improve patient care, benefit patients with complex conditions and set new standards for cardiac care in the region. A key focus area involves artificial intelligence-enabled digital biomarkers and cardiac imaging. With this collaboration, NHCS will contribute its extensive cardiovascular database of Asian populations, including significant findings from the landmark SingHeart1 study. Together, the institutions will evaluate and enhance the performance of AI-ECG algorithms across diverse Asian cohorts, ensuring their reliability, safety and efficacy.

3. Aging and frailty: The health of the aging population is an area of increasing concern. Early identification of cardiovascular aging using bio and digital markers, advanced imaging modalities, and prevention, including novel therapy, are of mutual interest.